AU2001250987A1 - Methods for detecting inflammation and inflammatory conditions - Google Patents
Methods for detecting inflammation and inflammatory conditionsInfo
- Publication number
- AU2001250987A1 AU2001250987A1 AU2001250987A AU5098701A AU2001250987A1 AU 2001250987 A1 AU2001250987 A1 AU 2001250987A1 AU 2001250987 A AU2001250987 A AU 2001250987A AU 5098701 A AU5098701 A AU 5098701A AU 2001250987 A1 AU2001250987 A1 AU 2001250987A1
- Authority
- AU
- Australia
- Prior art keywords
- methods
- inflammatory conditions
- detecting inflammation
- inflammatory
- detecting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56972—White blood cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70596—Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Mycology (AREA)
- Gastroenterology & Hepatology (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Methods for detecting the inflammatory biomarkers molecule CD 163 in biological samples are provided. Also provided are methods for monitoring the course of an inflammatory process or condition in a patient and compositions and methods for preventing and treating inflammation and inflammatory processes.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19252900P | 2000-03-28 | 2000-03-28 | |
US60192529 | 2000-03-28 | ||
PCT/US2001/009577 WO2001073435A1 (en) | 2000-03-28 | 2001-03-27 | Methods for detecting inflammation and inflammatory conditions |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001250987A1 true AU2001250987A1 (en) | 2001-10-08 |
Family
ID=22710051
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001250987A Abandoned AU2001250987A1 (en) | 2000-03-28 | 2001-03-27 | Methods for detecting inflammation and inflammatory conditions |
Country Status (10)
Country | Link |
---|---|
US (2) | US7144710B2 (en) |
EP (1) | EP1281083B1 (en) |
JP (1) | JP4777580B2 (en) |
AT (1) | ATE365321T1 (en) |
AU (1) | AU2001250987A1 (en) |
CA (1) | CA2404964A1 (en) |
DE (1) | DE60129015T2 (en) |
DK (1) | DK1281083T3 (en) |
ES (1) | ES2287115T3 (en) |
WO (1) | WO2001073435A1 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2334103T3 (en) * | 2000-10-16 | 2010-03-05 | Cytoguide Aps | THE FUNCTION OF A HAPTOGLOBIN-HEMOGLOBIN RECEIVER AND USES OF THE SAME. |
US7465555B2 (en) * | 2002-04-02 | 2008-12-16 | Becton, Dickinson And Company | Early detection of sepsis |
EP1367393A1 (en) * | 2002-05-27 | 2003-12-03 | MacroZyme B.V. | Methods for using the CD 163 pathway for modulating an immune response |
EP1836557A4 (en) * | 2004-11-19 | 2009-01-21 | Trillium Diagnostics Llc | SOFTWARE INTEGRATED FLOW CYTOMETRIC ASSAY FOR QUANTIFICATION OF THE HUMAN POLYMORPHONUCLEAR LEUKOCYTE Fc RI RECEPTOR (CD64) |
JP2009519960A (en) * | 2005-12-15 | 2009-05-21 | ナチュアメッド グループ コーポレーション | Preparation and use of sinomenine derivatives |
EP2488863A2 (en) * | 2009-10-12 | 2012-08-22 | Aarhus Universitet | Method of prognosis |
US20140030735A1 (en) * | 2011-03-07 | 2014-01-30 | Temple University - Of The Commonwealth System Of Higher Education | Biomarkers of chronic obstructive pulmonary disease |
US11913957B2 (en) * | 2011-12-21 | 2024-02-27 | Biodesix, Inc. | Compositions, methods and kits for diagnosis of lung cancer |
WO2017192965A2 (en) * | 2016-05-05 | 2017-11-09 | Integrated Diagnostics, Inc. | Compositions, methods and kits for diagnosis of lung cancer |
-
2001
- 2001-03-27 US US10/240,382 patent/US7144710B2/en not_active Expired - Fee Related
- 2001-03-27 CA CA002404964A patent/CA2404964A1/en not_active Abandoned
- 2001-03-27 US US09/817,950 patent/US20010041177A1/en not_active Abandoned
- 2001-03-27 JP JP2001571100A patent/JP4777580B2/en not_active Expired - Fee Related
- 2001-03-27 DK DK01924324T patent/DK1281083T3/en active
- 2001-03-27 DE DE60129015T patent/DE60129015T2/en not_active Expired - Lifetime
- 2001-03-27 WO PCT/US2001/009577 patent/WO2001073435A1/en active IP Right Grant
- 2001-03-27 AU AU2001250987A patent/AU2001250987A1/en not_active Abandoned
- 2001-03-27 ES ES01924324T patent/ES2287115T3/en not_active Expired - Lifetime
- 2001-03-27 AT AT01924324T patent/ATE365321T1/en not_active IP Right Cessation
- 2001-03-27 EP EP01924324A patent/EP1281083B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP1281083A1 (en) | 2003-02-05 |
ES2287115T3 (en) | 2007-12-16 |
DE60129015D1 (en) | 2007-08-02 |
DE60129015T2 (en) | 2008-02-21 |
DK1281083T3 (en) | 2007-10-22 |
US7144710B2 (en) | 2006-12-05 |
ATE365321T1 (en) | 2007-07-15 |
US20030215885A1 (en) | 2003-11-20 |
JP4777580B2 (en) | 2011-09-21 |
CA2404964A1 (en) | 2001-10-04 |
EP1281083B1 (en) | 2007-06-20 |
JP2003529080A (en) | 2003-09-30 |
US20010041177A1 (en) | 2001-11-15 |
WO2001073435A1 (en) | 2001-10-04 |
EP1281083A4 (en) | 2004-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1687283A4 (en) | Method and composition useful for determining fk 506 | |
MXPA02006145A (en) | Method for isolation of rna from formalinfixed paraffinembedded tissue specimens. | |
AU2751199A (en) | Method, apparatus and flow cell for high sensitivity detection of fluorescent molecules | |
AU2323399A (en) | Method and compositions for detecting luciferase in biological samples | |
AU5212199A (en) | Methods and kits for diagnosing and determination of the predisposition of diseases | |
AU2002320100A1 (en) | Methods for detecting and treating the early onset of aging-related conditions | |
WO2002066671A3 (en) | Improved method for detection of atp | |
AU4157696A (en) | Quantitative method for early detection of mutant alleles and diagnostic kits for carrying out the method | |
AU1628100A (en) | Bidirectional lateral flow test strip and method | |
AU2002249837A1 (en) | Homo-doubly labeled compositions for the detection of enzyme activity in biological samples | |
AU5778000A (en) | System and method for molecular sample measurement | |
AU2921001A (en) | Apparatus and method for removing small molecules and ions from low volume biological samples | |
AU1298701A (en) | Method and device for diagnosing an inflammatory process | |
AU4040097A (en) | Signal amplification method | |
WO2002008461A3 (en) | A METHOD AND AN ALGORITHM FOR mRNA EXPRESSION ANALYSIS | |
AU3416200A (en) | Method for determining the concentration of thrombin inhibitors | |
AU3401699A (en) | Method and apparatus for monitoring gas(es) in a dielectric fluid | |
AU6659698A (en) | Compositions, methods, kits and apparatus for determining the presence or absence of target molecules | |
WO2003032894A3 (en) | Method of monitoring neuroprotective treatment | |
AU2003207952A1 (en) | Methods and device for freezing and thawing biological samples | |
AU2001250987A1 (en) | Methods for detecting inflammation and inflammatory conditions | |
WO2004029285A3 (en) | Methods for detecting endocrine cancer | |
AU3516899A (en) | Method and probes for the detection of chromosome aberrations | |
AU2001292894A1 (en) | Method for monitoring resting and activated platelets in unfixed blood samples | |
AU7410600A (en) | Method for the determination of substances using the evanescence field method |